Procter & Gamble Tops Sales, Profit Estimates, Names New CEO

Procter & Gamble reported better-than-expected fiscal Q4 results, with core EPS of $1.48 and revenue up 2% year-over-year to $20.9 billion, surpassing analyst estimates. For fiscal 2026, the company projects all-in sales growth of 1-5% and core EPS flat to up 4% from FY25's $6.83, following analysts' forecast of $7.00 EPS. This performance comes amidst a recently announced leadership transition, with COO Shailesh Jejurikar set to become CEO in 2026, and a restructuring plan to cut 7,000 jobs and save up to $1.6 billion. P&G shares saw a modest gain of less than 1% post-report.

Analysis

Procter & Gamble's fiscal fourth-quarter results narrowly surpassed analyst expectations, with core EPS of $1.48 against a $1.43 consensus and a 2% year-over-year revenue increase to $20.9 billion, slightly above the $20.83 billion projection. This performance was driven by modest 2% sales growth in four of five segments, offset by flat sales in the Beauty division, indicating a lack of momentum in a key category. However, the market's muted reaction, with shares rising less than 1%, reflects a cautious outlook for fiscal 2026. The company's guidance for 1-5% sales growth and core EPS ranging from flat to up 4% brackets analyst forecasts but introduces uncertainty, particularly following a previous quarter where guidance was already cut due to challenging market conditions. This conservative forecast is contextualized by significant strategic shifts, including a major restructuring plan aimed at saving $1-1.6 billion through 7,000 job cuts and a planned leadership transition with COO Shailesh Jejurikar succeeding the CEO in 2026. These actions signal that while P&G is actively addressing underlying performance issues, the path to accelerated growth remains challenging.

Key Decisions for Investors

• Investors should weigh the current earnings beat against the cautious fiscal 2026 guidance, as the potential for flat EPS growth appears to be the primary factor capping upside potential.
• Monitor the execution and financial impact of the announced restructuring plan, as achieving the targeted $1-1.6 billion in savings is critical for supporting margins and meeting future earnings projections.
• Pay close attention to performance in the stagnant Beauty segment and any strategic shifts articulated by incoming CEO Shailesh Jejurikar, as these will be key indicators of the company's ability to reignite growth.